Zivo Bioscience, Inc. - Common Stock (OP:ZIVO)

9.500 UNCHANGED

Streaming Delayed Price Updated: 2:08 PM EST, Feb 26, 2026 Add to My Watchlist

Price and Volume

Volume	9
Open	9.500
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	9.500
Today's Range	9.500 - 9.500
52wk Range	6.953 - 21.00
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses

September 10, 2025

From ZIVO Bioscience, Inc.

Via Business Wire

ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry

June 20, 2025

From ZIVO Bioscience, Inc.

Via Business Wire

Performance

YTD	-4.2%	-4.2%
1 Month	+5.6%	+5.6%
3 Month	-16.5%	-16.5%
6 Month	-44.2%	-44.2%
1 Year	-54.8%	-54.8%

More News

University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry

May 06, 2025

From ZIVO Bioscience, Inc.

Via Business Wire

ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q2 2024 ↗

August 16, 2024

Via InvestorPlace

ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry

February 06, 2025

From ZIVO Bioscience, Inc.

Via Business Wire

ZIVO Bioscience to Present at The Microcap Conference 2025

January 22, 2025

From Zivo Bioscience, Inc.

Via Business Wire

ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities

December 23, 2024

From Zivo Bioscience, Inc.

Via Business Wire

ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza

December 20, 2024

From Zivo Bioscience, Inc.

Via Business Wire

ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens

August 23, 2024

From ZIVO Bioscience, Inc.

Via Business Wire

Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens

July 08, 2024

From ZIVO Bioscience, Inc.

Via Business Wire

Frequently Asked Questions

Is Zivo Bioscience, Inc. - Common Stock publicly traded?

Yes, Zivo Bioscience, Inc. - Common Stock is publicly traded.

What exchange does Zivo Bioscience, Inc. - Common Stock trade on?

Zivo Bioscience, Inc. - Common Stock trades on the OTC Traded

What is the ticker symbol for Zivo Bioscience, Inc. - Common Stock?

The ticker symbol for Zivo Bioscience, Inc. - Common Stock is ZIVO on the OTC Traded

What is the current price of Zivo Bioscience, Inc. - Common Stock?

The current price of Zivo Bioscience, Inc. - Common Stock is 9.500

When was Zivo Bioscience, Inc. - Common Stock last traded?

The last trade of Zivo Bioscience, Inc. - Common Stock was at 02/26/26 02:08 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.